Answers are grounded in this paper and cite their sources.
Congenital hypogonadotropic hypogonadism (CHH) and Kallmann syndrome (KS) are genetically heterogeneous disorders caused from impaired development or function of gonadotropin-releasing hormone (GnRH) neurons. ZNF462 variants cause Weiss–Kruszka syndrome (WKS), a neurodevelopmental disorder occasionally associated with endocrine abnormalities. We report two unrelated Japanese patients with CHH/KS who harbor de novo truncating variants in ZNF462. Case 1, harboring NM_021224.6:c.1845_1846del, p.(Arg616SerfsTer6), presented with CHH mild anosmia, and characteristic WKS features. Case 2, previously reported in a CHH cohort and harboring NM_021224.6:c.2431C>T, p.(Gln811Ter), presented with KS, anosmia, and olfactory tract abnormalities. Recent studies demonstrated that ZNF462 regulates neural lineage specification via G9A/GLP-mediated chromatin repression, and that ZNF family genes also participate in the epigenetic regulation of pubertal activation. These findings broaden the endocrine spectrum of ZNF462-related disorders and indicate that single-gene ZNF462 defects may contribute to GnRH deficiency through neurodevelopmental and epigenetic mechanisms.
No takes yet. Share an insight, caveat, or question.
Saitō et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: